{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:23:03Z","timestamp":1790392983848,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"am","delay-in-days":314,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006251","name":"Universit\u00e9 de Bordeaux","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006251","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.genhosppsych.2020.03.006","type":"journal-article","created":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T18:45:42Z","timestamp":1586025942000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Use of benzodiazepines non-compliant with guidelines in patients with psychiatric and non-psychiatric chronic disorders"],"prefix":"10.1016","volume":"65","author":[{"given":"Arnaud","family":"Panes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Verdoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Fourrier-R\u00e9glat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Driss","family":"Berda\u00ef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.psychres.2016.01.040","article-title":"Continuation and discontinuation of benzodiazepine prescriptions: a cohort study based on a large claims database in Japan","volume":"237","author":"Takeshima","year":"2016","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s002280100326","article-title":"Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use","volume":"57","author":"Fourrier","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00127-011-0344-1","article-title":"Ten-year trends in benzodiazepine use in the Dutch population","volume":"47","author":"Sonnenberg","year":"2012","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","article-title":"Benzodiazepine harm: how can it be reduced?","volume":"77","author":"Lader","year":"2014","journal-title":"Br J Clin Pharmacology"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0025","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0030","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: prospective population based study","volume":"345","author":"Billioti de Gage","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0035","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0040","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0045","author":"World Health Organization (WHO)"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0050","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.genhosppsych.2015.06.004","article-title":"Demographic and clinical factors associated with benzodiazepine prescription at discharge from psychiatric inpatient treatment","volume":"37","author":"Peters","year":"2015","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/fcp.12167","article-title":"Compliance of psychotropic drug prescription with clinical practice guidelines in older inpatients","volume":"30","author":"Etchepare","year":"2016","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112660","article-title":"Benzodiazepine abuse, misuse, dependence, and withdrawal among schizophrenic patients: a review of the literature","volume":"284","author":"de la Iglesia-Larrad","year":"2020","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00406-018-0966-3","article-title":"Use of benzodiazepines and z-drugs not compliant with guidelines and associated factors: a population-based study","volume":"270","author":"Panes","year":"2020","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"86","key":"10.1016\/j.genhosppsych.2020.03.006_bb0070","first-page":"601","article-title":"Misuse of benzodiazepines: prevalence and impact in an inpatient population with psychiatric disorders","volume":"2020","author":"Panes","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0075","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/pon.4328","article-title":"Incidence of depression and anxiety among women newly diagnosed with breast or genital organ cancer in Germany","volume":"26","author":"Jacob","year":"2017","journal-title":"Psychooncology"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0080","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1002\/cncr.30904","article-title":"Psychological distress associated with cancer screening: a systematic review","volume":"123","author":"Chad-Friedman","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jad.2017.04.050","article-title":"Risk of mood disorders in patients with colorectal cancer","volume":"218","author":"Sun","year":"2017","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0090","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/heartjnl-2016-310207","article-title":"Coronary heart disease and risk factors as predictors of trajectories of psychological distress from midlife to old age","volume":"103","author":"Virtanen","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0095","doi-asserted-by":"crossref","DOI":"10.1177\/2055102915624873","article-title":"Trajectories of depressive symptoms after a major cardiac event","volume":"3","author":"Mittag","year":"2016","journal-title":"Health Psychol Open"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12888-016-0986-3","article-title":"Depressive symptoms and functional decline following coronary interventions in older patients with coronary artery disease: a prospective cohort study","volume":"16","author":"Wilcox","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"142 Suppl","key":"10.1016\/j.genhosppsych.2020.03.006_bb0105","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0165-0327(12)70004-6","article-title":"Epidemiology of depression and diabetes: a systematic review","author":"Roy","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0110","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s11920-013-0390-3","article-title":"The comorbidity between depression and diabetes","volume":"15","author":"Oladeji","year":"2013","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00125-016-4123-0","article-title":"Trajectories of depression in adults with newly diagnosed type 1 diabetes: results from the German Multicenter Diabetes Cohort Study","volume":"60","author":"Kampling","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0120","series-title":"Rapport sur le bon usage des m\u00e9dicaments psychotropes","author":"Verdoux","year":"2006"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0125","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0959-8049(01)00136-8","article-title":"Psychiatric disorders and associated factors in cancer: results of an interview study with patients in inpatient, rehabilitation and outpatient treatment","volume":"37","author":"H\u00e4rter","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0130","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/pon.3056","article-title":"Prescription patterns for psychotropic drugs in cancer patients; a large population study in the Netherlands","volume":"22","author":"Ng","year":"2013","journal-title":"Psychooncology"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11764-016-0569-9","article-title":"Psychotropic drug dispensing in people with and without cancer in France","volume":"11","author":"Verger","year":"2017","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0145","doi-asserted-by":"crossref","unstructured":"Goldberg M, et al. [The REDSIAM network]. Rev Epidemiol Sante Publique 2017 Oct; 65 Suppl 4: S144-S148.","DOI":"10.1016\/j.respe.2017.06.001"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.respe.2015.12.020","article-title":"Estimation of breast, prostate, and colorectal cancer incidence using a French administrative database (general sample of health insurance beneficiaries)","volume":"64","author":"Doat","year":"2016","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.yco.0000165594.60434.84","article-title":"The diagnosis and management of benzodiazepine dependence","volume":"18","author":"Ashton","year":"2005","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0160","series-title":"The effects of tranquillization: benzodiazepine use in Canada","author":"Cooperstock","year":"1982"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0165","series-title":"Benzodiazepines-use & abuse, a guide for prescribers","author":"Smith","year":"1989"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0170","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsx147","article-title":"Eight-year follow-up of hypnotic delivery by adults aged 50 and older from an insurance database","volume":"40","author":"Verger","year":"2017","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.genhosppsych.2020.03.006_bb0175","article-title":"Benzodiazepines versus placebo for panic disorder in adults","author":"Breilmann","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.genhosppsych.2020.03.006_bb0180","article-title":"Antidepressants plus benzodiazepines for adults with major depression","author":"Ogawa","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0185","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.euroneuro.2013.03.001","article-title":"Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials","volume":"23","author":"Dold","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0190","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/j.1360-0443.2012.03975.x","article-title":"Correlates of benzodiazepine dependence in the Netherlands Study of Depression and Anxiety","volume":"107","author":"Manthey","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.genhosppsych.2020.03.006_bb0195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2296-12-28","article-title":"Gaining insight into benzodiazepine prescribing in general practice in France: a data-based study","volume":"12","author":"Rosman","year":"2011","journal-title":"BMC Fam Pract"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834320300402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834320300402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:50:34Z","timestamp":1759013434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834320300402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":38,"alternative-id":["S0163834320300402"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2020.03.006","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of benzodiazepines non-compliant with guidelines in patients with psychiatric and non-psychiatric chronic disorders","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2020.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}